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Role of vasopressin in impaired water excretion in conscious rats with
experimental cirrhosis. The present study was undertaken to study the
mechanism of impaired water excretion in experimental cirrhosis in the
rat. Conscious rats in whom histologically proven cirrhosis was induced
with carbon tetrachioride and phenobarbital were compared with
control rats given phenobarbital alone. Impaired water excretion in
experimental cirrhosis was verified by a basal hyponatremia (138 vs.
147 mEq/liter, P < 0.005) and an impaired excretion of water load
(minimal urinary osmolality, 262 vs. 100 mOsmlkg; 58 vs. 102% of water
load excreted, P < 0.001). To clarify the mechanism of this impaired
water excretion, we measured glomerular filtration rate (GFR), renal
blood flow (RBF), and vasopressin (VP) levels. In cirrhosis, GFR was
normal but RBF was decreased (4.5 vs 6.8 mllmin/g, P < 0.01). VP
levels were found to be higher in cirrhotic rats (1.61 vs. 0.71 pg/mI, P <
0.025). The significance of the impaired renal hemodynamics and the
increase in VP was assessed by inducing cirrhosis in VP-free Brattle-
boro (diabetes insipidus; DI) rats. Despite histologic, biochemical, and
renal hemodynamic changes that were comparable to cirrhotic rats with
an intact neurohypophysis, cirrhotic DI rats had no impairment in water
excretion. To determine the cause of increased VP in experimental
cirrhosis, we determined blood volume and systemic hemodynamics.
Although plasma volume was greater in experimental cirrhosis (4.3 vs.
3.0 mlIlOO g, P < 0.05), cirrhotic rats had a significantly lower
peripheral resistance (0.37 vs. 0.42 mm Hg/mi/mm/kg, P < 0.05) and
mean arterial pressure (104 vs. 120 mm Hg, P < 0.001) than did control
rats. These results document that experimental cirrhosis in the rat is
associated with impaired renal water excretion in association with both
abnormal renal hemodynamics and increased VP levels. The impaired
water excretion, however, is solely VP mediated. The nonosmolar
stimulus for VP release may be due to abnormal systemic hemodynam-
ics.
Role de Ia vasopressine dans l'altération de l'excrétion de l'eau par le
rat conscient atteint de cirrhose expérimentale. Cette étude a été
entrepnse pour élucider le mécanisme de l'altération de l'excrétion de
l'eau au cours de la cirrhose du rat. Des rats conscients chez lesquels
une cirrhose prouvée histologiquement a éte induite par le tétrachlorure
et le phénobarbital ont été compares a des rats contrôles recevant
seulement le phénobarbital. L'altération de l'excrétion de l'eau dans la
cirrhose experimentale a été vérifiée par l'hyponatrémie basale (138 vs.
147 mEq/litre, P < 0,005) et le défaut d'excrétion d'une charge en eau
(osmolalité urinaire minimale 262 vs. 100 mOsm/kg; 58 vs. 102% de Ia
charge d'eau sont excrétés, P < 0,001). Pour élucider le mécanisme de
cette alteration de l'excrétion de l'eau le debit de filtration glomérulaire
(GFR), le debit sanguin renal (RBF) et les concentrations de vasopres-
sine (VP) ont été mesurCs. Dans la cirrhose GFR est normal alors que
RBF est diminué (4,5 vs. 6,8 mI/mm/gm, P < 0,01). VP est plus ClevCe
chez les rats cirrhotiques (1,61 vs. 0,71 pg/ml, P < 0,025). La significa-
tion des modifications de l'hémodynamique rénale et de l'augmentation
de VP a été évaluée en créant des cirrhoses chez des rats sans VP de Ia
souche Brattleboro (DI). Malgré des modifications histologiques, bio-
chimiques et hemodynamiques rénales qui sont comparables a celles
des rats dont Ia neurohypophyse est intacte, les rats DI cirrhotiques
n'ont pas d'altération de l'excrétion de l'eau. Pour connaitre Ia cause de
l'augmentation de VP dans Ia cirrhose expérimentale Ic volume sanguin
et l'hémodynamique systémique ont Cte Ctudiés. Quoique le volume
plasmatique soit augmenté dans Ia cirrhose expérimentale (4,3 vs. 3,0
ml/100 g, P < 0,05) les rats cirrhotiques ont des resistances pCriphéri-
ques inférieures (0,37 vs. 0,42 mm Hg/mI/mm/kg, P < 0,05) et une
pression artérielle moyenne inférieure (104 vs. 120mm Hg, P < 0,001) a
celles des rats contrOles. Ces rCsultats indiquent que Ia cirrhose
expenmentale du rat comporte une alteration de l'excrétion de l'eau
associée a une hémodynamique rénale anormale et a des concentrations
de VP augmentées. L'altération de l'excrétion de l'eau, cependant, a Ia
vasopressione comme seul mCdiateur. Le stimulus non osmolaire de Ia
liberation de VP pourrait être l'anomalie de l'hémodynamique systé-
mique.
Derangements of renal function are frequently encountered in
patients with cirrhosis [1—5]. Among these derangements, an
impairment in renal water excretion that results in an inability
to excrete a water load and hyponatremia occurs in a substan-
tial number of individuals with liver disease [4, 6—10]. The
potential mechanisms responsible for this defect in water excre-
tion have been the subject of debate for many years.
Much of the controversy has revolved around the issue of
whether the defect is due primarily to intrarenal factors such as
abnormal delivery of fluid to the distal nephron or whether it is
mediated by an extrarenal mechanism involving vasopressin
release. The observation that maneuvers such as the infusion of
mannitol [111, saline [11], saline plus albumin [12], ascitic fluid
[13], and neck immersion [14] improve urinary dilution in
patients with cirrhosis does not help clarify the above contro-
versy because they presumably not only improve distal fluid
delivery but also expand extracellular fluid volume, a process
that would tend to suppress vasopressin secretion via the
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baroreceptor pathways. Studies in which the administration of
furosemide appear to improve free water excretion in cirrhotic
patients [15] lend support to the intrarenal hypothesis because it
involves no change or perhaps even a decrease in extracellular
fluid volume. But because a similar improvement in free water
generation with furosemide is seen in cirrhotic patients receiv-
ing exogenous vasopressin infusions, a role for persistent
release of the hormone in the diluting defect could not be
excluded. Experimental evidence supporting a role for vaso-
pressin has in fact been indirect and has involved improvement
of water excretion due to alcohol administration [161, an agent
that suppresses antidiuretic hormone (ADH) release [17], and
demeclocycline therapy [18], a drug that appears to antagonize
the peripheral action of the hormone. Finally, measurements of
hormone levels by bioassay in the urine and blood of patients
with cirrhosis have yielded conflicting results [19—241.
The recent description of animal models of cirrhosis, the
application of a sensitive radioimmunoassay for the measure-
ment of ADH, and the use of rats with the hereditary absence of
ADH have provided the opportunity to assess the role of ADH
in the cirrhotic rat. In the present study, we demonstrate that
cirrhotic rats have a defect in renal water excretion associated
with elevated levels of vasopressin. Because cirrhotic rats with
a congenital absence of vasopressin display no abnormality in
renal water excretion, it is apparent that this hormone is the
primary mediator of the impaired dilution of cirrhotic rats with
an intact vasopressin secretory mechanism.
Methods
Studies were performed on male Sprague-Dawley (SD) rats
and male rats of the Brattleboro strain with hereditary hypothal-
arnie diabetes insipidus (DI). Each rat weighed between 200 and
250 g at the beginning of the study. In DI rats, the absence of
vasopressin was supported by the finding of spontaneous
urinary osmolality of less than 200 mOsm/kg and the finding
that urinary osmolality (Uosm) did not increase above 600
mOsm/kg after 14 hours of fluid deprivation.
Induction of experimental cirrhosis. Hepatic cirrhosis was
induced in experimental SD rats by a modification of the
methods described by McLean, McLean, and Sutton [25] and
Lopez-Novoa et al [26—28]. In this model of cirrhosis, carbon
tetrachloride is used as a hepatotoxin. The addition of pheno-
barbital to the drinking water during the induction of cirrhosis
by carbon tetrachloride assures a high yield of cirrhotic animals
and shortens the time required to induce cirrhosis [25—28]. The
procedure consisted of adding phenobarbital 0.4 g/liter to the
drinking water throughout the entire induction process. After 1
week of receiving phenobarbital, rats received carbon tetra-
chloride, 0.2 cc/kg i.p. After 7 days, inhalation of carbon
tetrachloride was initiated. For gas inhalation, rats were placed
in a plexiglass chamber (72 x 45 x 46 cm; that is, 150-liter
capacity). Compressed air was passed via a flow meter (5
liters/mm) bubbling through a flask containing carbon tetrachlo-
ride (Fisher Scientific Co., C-570) and into the box. At the time
of gas exposure, the carbon tetrachloride vapor was delivered
for a given number of minutes followed by an equal number of
minutes of compressed air. The animals were dosed twice
weekly for at least 6 weeks. Beginning with a 5-mm exposure to
the gas, the amount of time that animals remained exposed to it
was increased by 1 mm every two sessions until by week 6 rats
received 5 liters/mm of carbon tetrachioride gas for 10 mm
followed by 5 liters/mm of compressed air for 10 mm. After this
6-week period of the gas inhalations, phenobarbital and carbon
tetrachloride were discontinued, and the animals were allowed
deionized water to drink. As has been previously noted [26], the
induction process is associated with approximately a 30%
mortality. Control animals drank phenobarbital throughout the
study but were not exposed to carbon tetrachloride. All rats
were allowed commercial rat chow ad lib. Following exposure
to carbon tetrachioride and phenobarbital, animals were al-
lowed to recover for at least 14 days before any protocol was
initiated.
DI rats were treated in the same manner as the SD rats except
that they received daily injections of 100 mU of Pitressin
tannate in oil (Parke Davis, Detroit, Michigan) for 1 week prior
to beginning phenobarbital and throughout the time of exposure
to carbon tetrachloride. From each group of 6 to 10 SD rats, 2 to
4 were studied histologically. Cirrhosis was found in each gas-
exposed rat whose liver was histologically examined. In addi-
tion, every SD rat that was exposed to the carbon tetrachloride
had a defect in water excretion that was quantitated before the
animal was used for further studies. Cirrhosis was verified
histologically in every DI rat after the completion of the
hemodynamic protocols.
Balance studies. Balance studies were undertaken to deter-
mine the nutritional status of the cirrhotic animals at the time
subsequent protocols were performed. Eight control SD and
eight cirrhotic SD rats were placed in individual metabolism
cages (Holtge Co., Cincinnati, Ohio) that allow for separation of
food, urine, and feces. Animals were fed a diet containing 85
mEq of sodium and 248 mEq of potassium per kg of food. Both
food and deionized water were allowed ad lib. After allowing 2
days for adaptation to the cages, the quantities of food ingested,
the animal weights, and the urine volume over 24 hours was
measured for 5 successive days as has previously been de-
scribed [29]. After this study, and following the removal of
water for 2 hours, the animals were anesthetized by the i.p.
injection of phenobarbital (60 mg/kg). Blood was obtained by
aortic puncture into heparinized tubes and was analyzed for
sodium, potassium, osmolality, SGOT [30], bilirubin [31], alka-
line phosphatase [32], albumin [33], and total protein [34]. Liver
and kidney slices were obtained and fixed in 10% formalin for
subsequent histologic evaluation.
Oral water loads in cirrhotic rats. To demonstrate the nature
of the defect in water excretion caused by cirrhosis, we
performed water loads in 12 phenobarbital-drinking and 12
cirrhotic SD rats. On each occasion, water loading was per-
formed 2 hours after removing food and water. Animals were
lightly anesthetized with ether and, following abdominal mas-
sage to assure emptying of their bladders, an oral water load (30
mI/kg body wt of tepid deionized water) was administered by
gastric tube. The animals were then placed in individual meta-
bolic cages where each spontaneously voided urine was collect-
ed. After 3 hours, following abdominal massage, a final urine
sample was obtained. The total volume excreted was recorded,
and the sample with the lowest osmolality was recorded as the
minimal osmolality.
Water loads were performed on two occasions separated by
at least 72 hours. In each rat, the results of both water loads
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were comparable. Thus, the mean of the two studies is present-
ed in the Results section. In earlier studies, the results of water
loading were not found to be influenced by repeated water loads
separated by 72 hours.
Intravenous sodium and water loads in cirrhotic animals. To
demonstrate the effect of cirrhosis on renal sodium excretion,
identical volumes of i.v. hypotonic solutions were administered
to 10 cirrhotic SD and 7 phenobarbital-drinking SD rats. The
animals were prepared for study with the use of ether, and
jugular venous, carotid arterial, and bladder catheters were
inserted. The animals were then allowed to awaken and recover
in restraining cages for 30 to 60 mm before any protocol was
begun. Following recovery, 4% inulin in 0.9% sodium chloride
was infused at a rate of 25 pil/min. During the subsequent 45
mm, an i.v. water load equivalent to 5% body wt was adminis-
tered as 2.5% dextrose. Three timed urine collections and a
midpoint blood sample were obtained, and the blood was
replaced with a equal volume of 0.9% sodium chloride. The
resulting diuresis was then augmented by the infusion of 0.45%
saline at rates of 0.2, 0.4, and 0.8 mI/mm. At each infusion rate,
the animal was allowed to equilibrate for 20 mm, following
which three urine samples and a midpoint blood sample were
obtained. No animal had glycosuria or hemolysis. Glomerular
filtration rate (GFR) was estimated from the clearance of inulin.
Osmolar clearance, free water clearance (CH2O) and fractional
sodium excretion (FENa) were calculated from standard formu-
lae. Distal sodium delivery was approximated from the sum of
[CNa + CH2O]/GFR because this term reflects distal nephron
fluid delivery in the absence of vasopressin [35]. All animals
were vasopressin-free during the 0.8-ml/min saline infusion as
evidenced by a U0sm less than 150 mOsm/kg. Distal nephron
sodium reabsorption was approximated by the formula
CH2O/[CNa + CioJ X 100%.
Effect of cirrhosis on plasma arginine vasopressin levels. To
correlate observed disturbances in water excretion with
changes in plasma vasopressin levels, we obtained plasma for
vasopressin from cirrhotic (N = 8) and control (N = 8) rats. In
this study, animals were water loaded and 60 mm later were
sacrificed by guillotine. Free-flowing blood issuing from the
trunk was collected in coded, chilled, heparinized tubes and
centrifuged at 00 C. Aliquots of plasma were analyzed for
sodium. The remaining plasma (approximately 2 ml) was stored
at —20° C and subsequently assayed for arginine vasopressin in
a blinded manner [361. The lower limit of sensitivity of the assay
is 0.5 pg/mI when 1 ml of plasma is extracted.
Effects of cirrhosis on water excretion in Bra ttleboro rats
with congenital absence of vasopressin. To determine the
contribution of vasopressin to the defect in water excretion, we
performed serial water loads in 5 cirrhotic rats with congenital
DI. These rats were treated identically to their SD controls with
the exception that each animal was water loaded on two
occasions prior to beginning phenobarbital and carbon tetra-
chloride administration. Following hemodynamic studies (vide
infra), we obtained plasma samples for subsequent biochemical
analysis. All DI rats were proven to have cirrhosis by histologic
examination.
Effect of cirrhosis on blood volume, systemic and renal
hemodynamics. Blood volume was determined in cirrhotic SD
rats (N = 6) and control (N 7) SD rats utilizing '251-albumin
by methods described by Thiel et a! {37j and Flamenbaum et al
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138]. A precise volume of '251-labeled human serum albumin
(Mallinckrodt Inc., St. Louis, Missouri) diluted in isotonic
saline was given i.v. with a micrometer syringe, and the
catheter was flushed with 0.2 ml of saline. The total radioactiv-
ity of the administered dose was determined by delivering at
least two identical volumes into counting vials. The range of
individual samples was less than 3%. Twenty minutes after the
injection, 0.4 ml of blood was withdrawn from a previously
cannulated carotid artery using a heparinized syringe. Hemoto-
crits were determined in duplicate samples, and at least two 0.1-
ml samples were obtained for isotope counting in a Beckman
gamma spectrophotometer.
Cardiac index (CI), systemic vascular resistance (SVR), renal
blood flow (RBF), and renal vascular resistance (RVR) were
determined by a radioactive microsphere technique that was
described originally for rats by Hsu, Kurtz, and Waldinger [39].
Seven conscious cirrhotic and 7 control SD rats were used for
study. The microspheres used were 8.8 0.9 in diameter and
were labeled with strontium 85. In addition, hemodynamic
studies were performed in 5 conscious cirrhotic Dl and 6
control DI rats. In preliminary studies in conscious, intact SD
rats, we determined that CI, SVR, RBF, and RVR were
comparable using 8.8-p. and 15-p. microspheres. In further
studies in 5 anesthetized SD rats, we obtained a continuous
collection of renal venous blood for 2 mm following left
ventricular injection of 8.8-p. microspheres. Counts obtained on
this renal venous blood were not different from background.
Sodium was determined by flame photometry and inulin by
standard autoanalyzer methods [40]. Osmolality was deter-
mined by cryoscopy with an osmometer (Advanced Instrument
3L). Statistical analyses were performed using the unpaired and
paired Student's t test. A P value less than 0.05 was considered
significant. Data are expressed as the mean SEM.
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Fig. 1. Daily cumulative sodium balance in control and cirrhotic
Sprague-Dawley rats.
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Table 1. Summary of plasma chemistries in cirrhotic Sprague-Dawley ratsa
Bilirubin
mg/dl GOT IU
Alkaline
phosphatase
JU
Total
protein
gidi
Albumin
gIdi
Sodium
mEqiliter
Plasma
osmolality
mOsm/kg H20
Potassium
mEqiliter
Control (N = 8) 0.18 0.03 88 11.5 193 25 5.8 0.08 3.84 0.05 146.6 1.0 292 2.5 4.01 0.13
Cirrhotic (N = 8) 0.50 0.08 137 19.0 376 11 6.3 0.10 3.69 0.08 137.9 2.0 273 2.9 3.91 0.10
P <0.005 <0.05 <0.001 <0.005 NS <0.005 <0.001 NS
a Values are the means SEM,
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FIg. 2. Effect of an acute water load on minimum urinary osmolality and
percentage excreted in cirrhotic Sprague-Dawley rats.
Results
Induction of experimental cirrhosis and balance studies.
Histologic examination of livers was similar to that described
by other [25—27] and showed moderate portal cirrhosis with
fibrosis, periportal chronic inflammation, bile duct prolifera-
tion, and destruction of liver architecture with formation of
regeneration nodules. Light microscopic evaluation of the kid-
neys from 12 cirrhotic rats was entirely normal. The histopa-
thology of cirrhotic SD rats was indistinguishable from cirrhotic
DI rats. Livers from rats drinking phenobarbital but not ex-
posed to carbon tetrachloride and livers from rats exposed to
carbon tetrachloride but not drinking phenobarbital appeared
normal on histologic examination.
Although rats appeared ill and lost weight for the 3 to 5 days
following i.p. carbon tetrachloride, they appeared well, ate, and
gained weight during the 6 weeks of inhalation of carbon
tetrachloride. Following exposure to carbon tetrachloride and
prior to being subjected to any further experimental protocol,
food intake (control, 20.5 1.2 glday; cirrhotic, 21.4 0.7
g/day) and weight gain (control, 14 I g per 5 days; cirrhotic,
15 1.5 g per 5 days) were comparable between control and
cirrhotic rats. Figure 1 depicts cumulative daily sodium balance
over a 5-day period for control and cirrhotic rats. As has been
noted in a recent study [28], cirrhotic rats were in positive
sodium balance by 170 iEq/day more than control rats (P <
0.05). Thus, it is probable that the weight gain in cirrhotic rats
during the balance period was partially due to the accumulation
of sodium and water.
Table 1 describes some blood studies obtained from these
animals. Cirrhotic rats had mild but significant increases in
bilirubin, plasma GOT, alkaline phosphatase, and total protein
when compared to control rats. Albumin concentrations were
comparable between the two groups of rats. In addition, the
spontaneous plasma sodium concentration (137.9 2.0 vs.
146.6 1.0 mEq/liter, P < 0.005) and plasma osmolality (273
2.9 vs. 292 2.5 mOsm/kg, P < 0.001) were significantly
decreased in the cirrhotic rats.
Oral waterloads in cirrhotic rats with an intact neurohypo-
physis (Fig. 2). The spontaneous hyponatremia observed in the
cirrhotic rats suggested a defect in water excretion in these rats.
To better define this defect, we administered oral water loads.
As is shown in Fig. 2, control rats had a minimum Uosm of 100.4
3.6 mOsm/kg and excreted 102.2 2.4% of the water load.
There was, however, a marked defect in water excretion in
cirrhotic rats: minimum U0sm was 262 11.6 mOsm/kg;
percentage excreted, 67.5 3.6%; both, P < 0.001 vs. control
rats. Water excretion was also found to be normal in 5 rats
exposed to carbon tetrachloride but not drinking phenobarbital
(Uosm, 98.6 4.8 mOsm!kg; percentage excreted, 96 4.5%).
Intravenous sodium and water loads in cirrhotic rats (Table
2). Results obtained during infusion with dextrose and during
the period of maximal absolute free water formation following
the administration of 0.8 ml/min hypotonic saline are presented
in Table 2. GFR was comparable between the two groups
during both dextrose and hypotonic saline infusion. During the
administration of dextrose, Uosm was 220 13 mOsm/kg in
cirrhotic rats, a value significantly greater than the value found
in control rats of 97 2.1 mOsm/kg, P < 0.001. Mean arterial
pressure was significantly decreased in cirrhotic rats (95.0 1.0
vs. 120.4 2.1 mm Hg, P < 0.001). Because the values
obtained after intravenous administration were similar to those
obtained after oral water loading, the possibility of impaired
water excretion caused by abnormal water absorption by the
intestine was excluded.
Following the infusion of hypotonic saline, cirrhotic rats were
able to dilute their urine to the same degree as control rats
(cirrhotic, 119 6 mOsmlkg; control, 108 6 mOsm/kg). As
opposed to the decrease in mean arterial pressure in cirrhotic
rats observed during dextrose infusion, mean arterial pressure
was comparable in cirrhotic and control rats during hypotonic
saline infusion. Estimated fractional distal nephron fluid deliv-
ery as estimated from these clearance studies was decreased in
cirrhotic rats (12.2 0.9 vs. 16.8 1.0%, P <0.01), and distal
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Table 2. Sodium excretion in cirrhotic Sprague-Dawley ratsa
2.5% Dextrose 0.45% Sodium chloride
GFR
mi/mm/kg
Uosm
mOsm/kg
MAP
mm Hg
GFR
mI/mm/kg
Uosm
mOsm/kg
MAP
mmHg
[CNa + CH20I/GFR
%
CH2O/[CNa +
% CH20I
FENa
%
Control (n = 7)
Cirrhotic(n=10)
P value
7.4 0.4
7.3±0.4
NS
97 2
220±13
<0.001
120 2
95±1
<0.001
9.4 0.3
9.6±0.7
NS
108 6
119±6
NS
125 3
124±4
NS
16.8 1.0
12.2±0.9
<0.01
55 3
68±3
<0.02
7.7 0.4
4.0±0.4
<0.01
Data noted is at times of maximal urinary dilution. Values are the means SEM. Abbreviations are GFR, glomerular filtration rate; Uosm,
urinary osmolality; MAP, mean arterial pressure; CNa, sodium clearance; CH2O, free water clearance; FENa, fractional excretion of sodium.
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nephron sodium reabsorption was increased in cirrhotic rats (68
3 vs. 55 3%, P < 0.02). The net result of these estimated
changes in segmental sodium transport was that fractional
sodium excretion was decreased in cirrhotic rats (4.0 0.4 vs.
7.7 0.4%, P < 0.01). These observations are thus in agree-
ment with the more direct micropuncture results seen in this
experimental model [271. Thus, when cirrhotic rats were chal-
lenged with a sodium load, there was an increase in sodium
reabsorption throughout the nephron and a marked decrease in
urinary sodium excretion.
Plasma arginine vasopressin levels in cirrhotic rats (Fig. 3).
To determine if increased vasopressin levels could account for
the observed abnormalities in water excretion, we measured
plasma vasopressin levels following an oral water load in
cirrhotic rats. Plasma arginine vasopressin levels were signifi-
cantly elevated in cirrhotic rats when compared to control rats
(1.61 0.33 vs. 0.71 0.11 pg/ml, P < 0.025). Because the
sensitivity of the assay is 0.5 pg/ml, this value was used in
samples reported as undetectable. Such was the case in 4 of 8
controls but not in any cirrhotic rats. The noted means there-
fore underestimate the difference in plasma arginine vasopres-
sin levels between the two groups. In addition, whereas the
mean Uosm of the control rats was 120 0.3 mOsm/kg, only 3
of the cirrhotic rats had spontaneously voided at the time of
sacrifice (Uosm, greater than 250 mOsm/kg).
Water excretion in cirrhotic rats with the congenital absence
of vasopressin (Fig. 4). To determine the physiologic signifi-
cance of the elevated vasopressin levels in cirrhotic rats, we
performed studies in DI rats. Cirrhotic DI rats had histologic
and liver functional anormalities that were comparable to
cirrhotic SD rats: bilirubin, 0.54 0.1 mg/dl; GOT, 144 20
IU; alkaline phosphatase, 367 43 IU. Plasma sodium concen-
tration, however, was comparable to untreated DI rats in our
laboratory: cirrhotic DI, 145.6 1.03 (N = 5); control DI rats,
147.4 1.1 mEq/liter (N = 6). Following a water load, control
DI rats with the hereditary absence of vasopressin had a
minimum Uosm of 103.4 2.9 mOsm/kg and excreted 142.6
2.2% of the water load. In cirrhotic DI rats, water excretion was
identical to control DI rats (minimum Uosm, 104.6 2.4
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Fig. 4. Effect of an acute water load on minimum urinary osmolality and
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Fig. 3. Relationship between plasma arginine vasopressin levels and
plasma sodium concentration following an oral water load in Sprague-
Dawley rats.
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Table 3. Blood volume in cirrhotic Sprague-Dawley ratsa
Weight Blood volume Hematocrit
g ml/JOO g vol %
Plasma volume
ml/100 g
Control (N = 7) 383 8 5.35 0.5 43.8 1.4
Cirrhotic (N = 6) 386 18 7.32 0.5 41.6 2.6
P NS <0.01 NS
3.03 0.25
4.33 0.45
<0.05
a Values are the means SEM.
Table 4. Hemodynamic studies in cirrhotic Sprague-Dawley and Brattleboro diabetes insipidus ratsa
Mean Systemic Renal
arterial pressure Cardiac index vascular resistance blood flow
mm Hg mi/mm/kg mm Hg/mi/mm/kg mllmin/g
Renal
vascular resistance
mm Hg/mllmin/g
Sprague-Dawley rats
(intact neurohypophysis)
Control (N = 7) 120 1 283 6 0.42 0.01 6.77 0.13
Cirrhotic (N = 7) 104 3 286 15 0.37 0.02 4.46 0.35
P <0.001 NS <0.05 <0.001
Brattleboro rats
(central diabetes insipidus)
Control (N = 7) 122 2 292 8 0.41 0.01 6.22 0.21
Cirrhotic (N = 7) 100 3 288 12 0.35 0.02 4.11 0.32
P <0.001 NS <0.025 <0.001
17.72 0.28
24.34 2.22
<0.02
19.6 0.6
24.3 1.8
<0.05
Values are the means SEM.
mOsm/kg; 139.4 4.8% excreted). Thus, in the absence of
vasopressin, water excretion was normal in cirrhotic rats.
These results provide strong evidence that the mechanism of
the defect in water excretion in cirrhotic rats with an intact
neurohypophysis is mediated by vasopressin rather than by a
decrease in distal nephron fluid delivery.
Blood volume and hemodynamics in cirrhotic rats (Tables 3
and 4). As is shown in Table 3, both whole blood and plasma
volumes were increased in cirrhotic rats. It is possible, howev-
er, that although total plasma volume was increased in cirrhotic
rats, the albumin distribution space may have differed between
the two groups of rats. Despite the probable increase in blood
volume, there were marked hemodynamic changes in cirrhotic
rats. Mean arterial pressure was decreased in cirrhotic rats (104
3.2 vs. 120 1.2 mm Hg, P < 0.001). This decrease in mean
arterial pressure was caused by a decrease in SVR in cirrhotic
rats (0.37 0.02 vs. 0.42 0.01 mm Hg/mI/mm/kg, P < 0.05)
because the CI was comparable to control rats.
Although GFR was comparable to control rats (Table 2),
cirrhotic rats had a significant decrease in RBF (4.46 0.35 vs.
6.77 0.13 ml/min/g, P < 0.001), and a significant increase in
RVR (24.34 2.2 vs. 17.72 0.28 mm Hg/ml/min/g, P < 0.02).
As compared with control DI rats, cirrhotic DI rats also had
significant decreases in mean arterial pressure, SVR, and RBF,
whereas there was a significant increase in RVR, thus com-
pletely mimicking the hemodynamic changes noted in SD
cirrhotic rats.
Discussion
In the present study we systematically investigated the
mechanism of the abnormal water excretion in experimental
cirrhosis by using a model of the disease in rats. The model used
in this study for induction of chronic liver disease results in the
development of many of the features observed in patients with
early chronic alcoholic portal cirrhosis. Rats exposed to pheno-
barbital and carbon tetrachloride developed mildly abnormal
liver function abnormalities and histologic abnormalities consis-
tent with cirrhosis. As in some patients with compensated
cirrhosis [41], cirrhotic rats were free of ascites but when
challenged with a sodium load were unable to excrete sodium
normally (Table 2). The sodium-retaining characteristics of this
experimental model of cirrhosis have also been documented by
others using both balance and micropuncture techniques [27,
28, 42]. There were also hemodynamic and renal functional
abnormalities that are often seen in patients with cirrhosis [1—
10, 43—47]. In this regard, blood volume was increased whereas
systemic vascular resistance and arterial pressure were signifi-
cantly decreased. As in early human cirrhosis, GFR was well
maintained, RBF was decreased, and RVR was increased.
There are differences between this experimental model of liver
disease and cirrhosis in patients. In particular, although im-
paired water excretion has been described in the compensated
cirrhotic patient [41], it is uncommon. Moreover, hyponatremia
is uncommon in the absence of ascites. Despite these differ-
ences, we feel that this is an acceptable experimental model for
the study of water excretion. We chose to study rats prior to the
development of ascites because at that time the rats appeared
well, ate and gained weight at the same rate as control rats.
Because, in the absence of ascites, cirrhotic rats developed a
reproducible defect in water metabolism without decrements in
glomerular filtration, they appeared ideally suited for a study of
the mechanism of the defect in water excretion in the absence of
a failing kidney.
Although carbon tetrachloride has been reported to cause
renal functional abnormalities [48], there was no evidence to
suggest that it was a nephrotoxin in this study. As opposed to
the renal functional changes that might have been expected to
occur in rats with toxic nephropathy, cirrhotic rats had a normal
GFR and have enhanced rather than decreased renal sodium
reabsorption. Moreover, light microscopic evaluation of kid-
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neys obtained from cirrhotic rats was entirely normal. It thus
appears that the observed diluting defect is not a consequence
of carbon tetrachioride-induced nephrotoxicity. These findings
also suggested that in this model of cirrhosis, carbon tetrachlo-
ride increases renal vascular resistance indirectly by causing
hepatic dysfunction.
The pathogenesis of the impairment in water excretion in
cirrhosis has been attributed to either a decrease in the delivery
of filtrate to the diluting segment of the nephron or to an
increase in vasopressin activity [11—14, 16, 19—241. Both of
these mechanisms could have occurred in cirrhotic SD rats.
Distal nephron fluid delivery as estimated by clearance tech-
niques (Table 2) and by micropuncture studies was found to be
decreased in cirrhotic rats [27]. In addition to the decrease in
distal nephron delivery, plasma arginine vasopressin levels
were significantly elevated in cirrhotic rats. To our knowledge,
this is the first demonstration of an increase in radioimmunoas-
sayable arginine vasopressin levels in cirrhotic rats or humans
following a water load. But, the presence of arginine vasopres-
sin in the circulation does not in itself define the relative roles of
the hormone and of the observed intrarenal factors in the
pathogenesis of the abnormal excretion of water.
The availability of Brattleboro rats with the hereditary ab-
sence of vasopressin allowed for distinguishing which of these
two possibilities was the pathogenic mechanism of impaired
water excretion in cirrhosis. Cirrhotic DI rats, who had distur-
bances in systemic and renal hemodynamics that were indistin-
guishable from cirrhotic rats with an intact neurohypophysis,
did not have a defect in water excretion. It is of interest that
similar findings have been reported in a patient with cirrhosis
and central DI [49]. This patient had a normal response to water
loading during severe decompensation. Thus, the defect in
water excretion in cirrhotic rats with an intact neurohypophysis
was related to vasopressin. Furthermore, the results obtained in
cirrhotic DI rats exclude the possibility that the defect in water
excretion is due to a vasopressin independent increase in water
permeability of the collecting duct in the cirrhotic rats or some
other nonspecific consequence of carbon tetrachloride.
The present study also provides some insights as to the
mechanism of enhanced vasopressin activity associated with
experimental cirrhosis in the rat. Cirrhotic rats had a defect in
water excretion associated with elevated levels of plasma
vasopressin as measured by radioimmunoassay. This defect in
water excretion was accompanied by a diminished plasma
sodium concentration, an osmotic effect that alone should have
suppressed vasopressin release. Moreover, the elevated levels
of vasopressin were associated with an increase in plasma
volume, a nonosmotic effect that should also have suppressed
vasopressin release [501. There was, however, a significant
decrease in systemic vascular resistance and in arterial pres-
sure, both of which are known nonosmotic stimuli for the
release of vasopres sin [50]. It would appear likely that the
nonosmotic stimulus for vasopressin release in cirrhotic rats
was mediated by these decreases in systemic hemodynamics.
As in human cirrhosis, the pathophysiologic cause of the
decrease in systemic resistance remains to be elucidated.
Another possible mechanism for the increase in vasopressin
activity in the cirrhotic rats is that there may have been
abnormalities in the metabolic clearance of vasopressin. Al-
though earlier studies suggested that there was no decreased
capacity to inactivate either endogenous or exogenous ADH in
cirrhosis [51, 53], recent preliminary studies by Skowsky, et al
[54] have demonstrated a decreased metabolic clearance rate of
arginine vasopressin in six patients with alcoholic cirrhosis.
Although the present study was not designed to assess arginine
vasopressin kinetics in rats with cirrhosis, the ability of cirrhot-
ic rats to rapidly and maximally dilute their urine following
hypotonic volume expansion with 0.45 M saline would suggest
that there is no defect in the metabolic clearance of vasopressin
in these rats. Further kinetic studies using the radio-
immunoassay will be necessary to determine the contributions
of abnormalities in production and clearance to the enhanced
vasopressin activity in cirrhotic rats.
In summary, the present results confirm an earlier demon-
stration that it is possible to produce an experimental model of
chronic liver disease in the rat resembling cirrhosis. Cirrhotic
rats have impaired water excretion that is associated with
impaired renal hemodynamics and increased plasma vasopres-
sin levels as measured by radioimmunoassay. In cirrhotic
Brattleboro rats with hereditary hypothalamic DI, there was no
defect in water excretion, thus demonstrating that the mecha-
nism of impaired water excretion in cirrhotic rats with an intact
neurohypophysis was primarily vasopressin mediated. The
findings of this study do not exclude the possibility that changes
in renal hemodynamics contribute to impaired water excretion
under other circumstances; for example, in the severely decom-
pensated edematous, ascitic patient with cirrhosis. The patho-
physiologic mechanism for enhanced vasopressin activity is
likely to be mediated by known nonosmotic stimuli, namely, a
decrease in peripheral resistance and in arterial pressure.
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